Kristian Humer
Chief Financial Officer · 4D Molecular Therapeutics, Inc.
Individual
- 2025
- Dec 11, 2025
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristian Humer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Kirn - $5.01M in FDMT purchases and sales in the last 12 months
- Scott Bizily - $364K in FDMT purchases and sales in the last 12 months
- Ashoo Gupta - $7K in FDMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristian Humer?
Kristian Humer is a corporate insider, tracked as Chief Financial Officer of 4D Molecular Therapeutics, Inc. (FDMT). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kristian Humer last file a Form 4?
The most recent primary Form 4 on record is dated 11 December 2025, one of 2 filings going back to 2025.
